5-fluoro-2,2'-cyclocytidine has been researched along with diaziquone in 1 studies
| Studies (5-fluoro-2,2'-cyclocytidine) | Trials (5-fluoro-2,2'-cyclocytidine) | Recent Studies (post-2010) (5-fluoro-2,2'-cyclocytidine) | Studies (diaziquone) | Trials (diaziquone) | Recent Studies (post-2010) (diaziquone) |
|---|---|---|---|---|---|
| 5 | 1 | 0 | 204 | 22 | 6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meyers, PA; Redner, A; Steinherz, PG; Tan, CT | 1 |
1 other study(ies) available for 5-fluoro-2,2'-cyclocytidine and diaziquone
| Article | Year |
|---|---|
Diaziquone and 2,2'-anhydro-arabinosyl-5-fluorocytosine for the treatment of children with relapsed or refractory acute nonlymphoblastic leukemia.
Topics: Adolescent; Ancitabine; Antineoplastic Agents; Aziridines; Benzoquinones; Bone Marrow; Cell Survival; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male | 1989 |